More SEC Filings

View Older Stories

Aug 14, 2026 04:32PM Form SCHEDULE 13G/A Bakkt, Inc. Filed by: Alyeska Investment Group, L.P.

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Health Catalyst, Inc. Filed by: Stoney Lonesome HF LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Avidbank Holdings, Inc. Filed by: Fourthstone LLC

Aug 14, 2026 04:31PM Form 10-Q FEMASYS INC For: Jun 30

Aug 14, 2026 04:31PM Form 8-K Seritage Growth Properti For: Aug 14

Aug 14, 2026 04:31PM Form 13F-HR Visualize Group LP For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A AMC ENTERTAINMENT HOLDIN Filed by: Pentwater Capital Management LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G Conexeu Sciences Inc. Filed by: OnePointTwo Capital Ventures LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Nine Energy Service, Filed by: GENDELL JEFFREY L

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Arcellx, Inc. Filed by: Paradigm Biocapital Advisors LP

Aug 14, 2026 04:31PM Form 13F-NT D. E. SHAW & CO, L.P. For: Jun 30

Aug 14, 2026 04:31PM Form NT 10-Q Bravo Multinational Inc. For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A BRC Inc. Filed by: Alyeska Investment Group, L.P.

Aug 14, 2026 04:31PM Form SCHEDULE 13G Cerebras Systems Inc. Filed by: Atreides Management, LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: MONTANOVA CAPITAL, LLC

Aug 14, 2026 04:31PM Form N-CEN Kurv ETF Trust For: May 31

Aug 14, 2026 04:31PM Form N-PX Carlyle Group Inc. For: Jun 30

Aug 14, 2026 04:31PM Form S-3 60 DEGREES PHARMACEUTICA

Aug 14, 2026 04:31PM Form SCHEDULE 13G First Tracks Biotherapeu Filed by: TCG Crossover GP II, LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A BANK OF THE JAMES FINANC Filed by: Fourthstone LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: Caligan Partners LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Paradigm Biocapital Advisors LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G Organon & Co. Filed by: Pentwater Capital Management LP

Aug 14, 2026 04:31PM Form 13F-HR Hound Partners, LLC For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A MASIMO CORP Filed by: Pentwater Capital Management LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G SPS COMMERCE INC Filed by: DISCIPLINED GROWTH INVESTORS INC /MN

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A SKYX Platforms Corp. Filed by: Alyeska Investment Group, L.P.

Aug 14, 2026 04:31PM Form 25-NSE Myseum.AI, Inc. Filed by: Nasdaq Stock Market LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A InflaRx N.V. Filed by: MONTANOVA CAPITAL, LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G TXNM ENERGY INC Filed by: Pentwater Capital Management LP

Aug 14, 2026 04:31PM Form N-PX Opus Capital Group, LLC For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Pentwater Capital Management LP

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP

Aug 14, 2026 04:31PM Form 13F-NT Fortress Credit Opportun For: Jun 30

Aug 14, 2026 04:31PM Form 10-Q BIOLARGO, INC. For: Jun 30

Aug 14, 2026 04:31PM Form 13F-HR Ampersand Capital Group, For: Jun 30

Aug 14, 2026 04:31PM Form 13F-NT Coatue Structured Co-Inv For: Jun 30

Aug 14, 2026 04:31PM Form 13F-HR Greycroft LP For: Jun 30

Aug 14, 2026 04:31PM Form 13F-NT Pershing Square Manageme For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Bleichroeder Acquisition Filed by: Alyeska Investment Group, L.P.

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: MONTANOVA CAPITAL, LLC

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A BATTALION OIL CORP Filed by: Alyeska Investment Group, L.P.

Aug 14, 2026 04:31PM Form 4 Arteris, Inc. For: Aug 12 Filed by: Hawkins Nicholas B.

Aug 14, 2026 04:31PM Form 8-K OPKO HEALTH, INC. For: Aug 13

Aug 14, 2026 04:31PM Form 8-K TUTOR PERINI CORP For: Aug 11

Aug 14, 2026 04:31PM Form 13F-NT DME Advisors, LP For: Jun 30

Aug 14, 2026 04:31PM Form 13F-NT Fortress Credit Opportun For: Jun 30

Aug 14, 2026 04:31PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P

View Older Stories